342898-59-3Relevant academic research and scientific papers
NOVEL ANTIESTROGENIC HETEROCYCLIC COMPOUNDS
-
, (2018/08/20)
The present invention provides novel heterocyclic compounds of Formula I wherein A, B, E, ring Z, Y, L, ring X, D, m, n, R7 and R8 are as defined in the specification as estrogen receptor antagonists/degraders. The compound of Formula I can be used for the treatment of cancers mediated by estrogen receptors. (Formula I ).
Compounds with hydroxycarbonyl-halogenoalkyl side chain
-
, (2008/06/13)
The present invention provides a compound consisting of a moiety and a group chemically bonded to said moiety, wherein said moiety contains a compound having low activity following oral administration or its parent scaffold and said group has the followin
